Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Nanotechnology Programs at FDA

Nanotechnology Programs at FDA

                        Nanotechnology Guidance Documents
          Nanotechnology Task Force Home
          Science & Research
          Science and Research Special Topics
          Nanotechnology Programs at FDA
          Office of the Commissioner Nanotechnology ProgramsNanotechnology Programs at FDA Office of the Commissioner Nanotechnology Programs
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe Office of the Commissioner, in partnership with the FDA Nanotechnology Task Force, facilitates communication and cooperation across the agency on nanotechnology regulatory science research, both within FDA and with national and international stakeholders. The FDA Nanotechnology Task Force provides the overall coordination of FDA’s nanotechnology regulatory science research efforts in the following programmatic investment areas:**Supporting Nanotechnology Core Facilities**Nanotechnology Core Facilities provide for laboratory testing capacity at FDA. In line with the FDA Nanotechnology Task Force report of July 2007, top tier priorities consist of: (1) Developing testing methods to assess the safety of products that use nanomaterials (including their stability and interaction with biological systems); (2) Developing testing methods to assess the quality and effectiveness of products that use nanomaterials; and (3) Developing standards to be incorporated in the safety assessment of products that contain nanomaterials or otherwise involve the application of nanotechnology.**Enhancing Staff Training and Professional Development**FDA has established a program to train staff to evaluate the scientific data submitted in support of regulatory applications that involve nanotechnology. Course work covers: (1) Cooperative training and research work within FDA, at national laboratories, and at government sponsored research centers; (2) FDA activities that engage and allow for information exchange and coordination with stakeholders, other government agencies, and international counterparts; and (3) Strengthening FDA nanotechnology scientific staff training and professional development opportunities.**Collaborative Opportunities for Research Excellence in Science (CORES) Program**There are many types of products where the FDA is currently the only federal agency to conduct research essential to inform science-based regulatory decisions, such as those related to safety and/or risk assessments. While the agency can undertake some self-initiated research, the scale and range of issues and expertise involved necessitate collaborations with academic and government laboratories. FDA has established a Nanotechnology CORES Program to foster collaborative and interdisciplinary research addressing product characterization and safety. The nanotechnology CORES program supports peer reviewed research at FDA, in collaboration with academia and government stakeholders.**For further information:**Office of the Chief Scientist-NanotechnologyFood and Drug AdministrationFDA White Oak Campus 10903 New Hampshire AvenueSilver Spring, MD 20993 Email: nanotechnology@fda.hhs.gov

                                                                                  Content current as of:
      03/19/2018Nanotechnology Programs at FDA

          
                        Nanotechnology Guidance Documents
          Nanotechnology Task Force
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop